HDAC INHIBITOR AND ANTIBODY AGAINST PD-L1 FOR TREATMENT OF OVARIAN CANCER

• 收藏
• 分享

专利权人:

СИНДАКС ФАРМАСЬЮТИКАЛЗ, ИНК. (US);ПФАЙЗЕР ИНК. (US);МЕРК ПАТЕНТ ГМБХ (DE)

发明人:

ОРДЕНТЛИХ, Питер (US),МЕЙЕРС, Майкл (US)

申请号：

RU2018127640

公开号：

RU2018127640A

申请日:

2016.12.28

申请国别(地区):

RU

年份:

2020

代理人:

摘要：

Described herein are methods for the treatment of heavily pre-treated recurrent ovarian cancer. In particular, methods are provided for the treatment of heavily pre-treated recurrent ovarian cancer with a combination of entinostat and an anti-PD-L1 antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/